Systemic Psoriasis Therapy Linked to Higher Symtomatic UTI Risk in Women
Use of cyclosporine, infliximab, and anti-IL17 agents may be associated with increased risk of symptomatic urinary tract infection in women with psoriasis.
Psoriasis Information Center
AAD and NPF Release Clinical Guideline on UV Therapy for Managing Psoriasis
A clinical guideline for the use of phototherapy for the care and management of adult patients with psoriasis developed by the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) has been published.
Biologic Treatment for Psoriasis May Reduce Coronary Inflammation
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography.
Importance of Type vs Number of Comorbidities in Psoriatic Arthritis
Type, rather than number, of comorbidities, has a greater effect on the quality of life of patients with psoriatic arthritis, according to recent research.
Psoriasis Patients Often Use Complementary, Alternative Medicine When Traditional Meds Fail
41, 39.5 percent use alternative, complementary therapies; higher use seen with severe psoriasis.
Abdominal Obesity May Raise Risk for Psoriasis
High waist circumference, regardless of overall body mass index, tied to higher risk.
Higher Risk for Mental Disorders Seen in Patients With Psoriasis
Time to onset found to be 2 to 3 months for anxiety disorders and other conditions.
Apremilast Effective for Patients Dissatisfied With Topical Corticosteroids
Addition of apremilast to a regimen of topical corticosteroids was safe and effective in patients with moderate plaque-type psoriasis.
Treatment Effect of Halobetasol Propionate/Tazarotene Combination Lotion for Plaque Psoriasis
A fixed-dose combination lotion comprised of halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) is more effective for treating moderate-to-severe plaque psoriasis than either component alone.
Halobetasol Propionate/Tazarotene Combination Lotion May Offer Sustained Symptomatic Relief in Plaque Psoriasis
Researchers completed 2 post hoc analyses of large, double-blind trials examining the efficacy of HP/TAZ combination therapy for clinically meaningful outcomes.
Guideline Covers Extracutaneous Manifestations of Psoriasis
The extracutaneous manifestations of psoriasis and guidance on use of biologic treatment for management of psoriasis are discussed in 2 new guidelines.
Hypertension With Psoriasis Tied to More Cardiac Interventions
In patients with hypertension, psoriasis linked to increased risk for cardiovascular procedures, surgeries.
Novel Scoring System Can Up Access to Biologics in Psoriasis
DLQI-R allows more patients to achieve threshold for becoming candidates for biologic treatment.
Psoriasis Linked to Increased Risk for Inflammatory Bowel Disease
Psoriasis appears to be significantly associated with inflammatory bowel disease.
Alternative Medicines May Aid in the Treatment of Psoriasis
Most studies evaluated fish oil, acupuncture, indigo naturalis, curcumin, meditation.
Psoriasis Treatment With Biologics Often Requires Multiple Courses, Treatment Changes
The final analysis set comprised biologic-naïve individuals — individuals who had filled an initial prescription for etanercept, infliximab, adalimumab, or ustekinumab after 2 years without using any biologic agent during the study period.
Comorbidity risks increase in children with psoriasis
Some of the comorbidities include increased lipid levels, hypertension, and diabetes.
Methotrexate vs tumor necrosis factor inhibitors for pediatric psoriasis
Medication-related adverse events occur more frequently with methotrexate in children with moderate to severe psoriasis.
Severe psoriasis linked to higher mortality risk
Patients with psoriasis whose disease affects >10% of their body surface area (BSA) are at an increased risk for death compared with the general population.
Sleep disturbance in psoriasis leads to psychological and physical predictors
Sleep complaints among individuals with psoriasis warrant greater clinical attention, as they have a greater chance for developing obstructive sleep apnea.
Want to read more?
Please login or register first to view this content.
